Little is known about the importance of the hepatitis C virus (HCV) NS3 protease in acute hepatitis C. In this prospective study, 82 consecutive patients with acute hepatitis C and human immunodeficiency virus (HIV) coinfection were enrolled. Individuals were infected with highly related HCV strains and the baseline NS3 quasispecies diversity and complexity was higher compared to a chronic hepatitis C control group (Po 0.0001). Both parameters were comparable in patients with spontaneous clearance (n ¼ 6) versus treatment-induced SVR (n ¼ 5) or development of chronic hepatitis C (n ¼9). Longitudinal NS3 quasispecies kinetics showed a trend to a decreasing diversity and complexity (Po 0.05) within 4 weeks in patients with spontaneous clearance compared to the other groups. The innate immune signalling protein CARDIF was cleaved to a similar extent independent of the outcome. Together with a more pronounced viral load decline (Po 0.05), an early decreasing NS3 quasispecies evolution indicates spontaneous clearance of acute hepatitis C.
Introduction
An acute HCV infection develops several weeks after HCV exposure and in the majority of cases is not associated with specific signs of liver disease. Approximately 25% of HCV monoinfected patients spontaneously clear the infection while the majority progress to chronic hepatitis C defined as the persistence of HCV-RNA beyond 6 months after infection (Grebely et al., 2011) . While before detection of the virus in 1989 the most frequent transmission route was by blood transfusion currently in industrialized countries the majority of new infections occur in patients with i.v. (intravenous) drug abuse and men who have sex with men (MSM). Especially in the last years several outbreaks of sexually transmitted acute hepatitis C infections in HIV-positive MSM have been reported (Danta et al., 2007; Ingiliz et al., 2014; van de Laar et al., 2009) . As the identification of patients with a high chance for a spontaneous clearance is of interest, several studies identified host factors, like IL28B genotype (Grebely et al., 2014; Liu et al., 2012; Thomas et al., 2009) , HLA genotypes Neumann-Haefelin et al., 2011) , combinations of both (Fitzmaurice et al., 2015) , interferon (IFN)-lambda 4 gene variations (Aka et al., 2014; Terczyńska-Dyla et al., 2014) as well as HCV-specific T-cell and neutralizing antibody responses (Bowen and Walker, 2005; Rehermann, 2009 ) in association with the outcome of acute hepatitis C. Viral factors, as the HCV genotype (GT) (Grebely et al., 2014) , the initial HCV viral load (Liu et al., 2012) and changes within the hypervariable region (HVR) 1 quasispecies probably also contribute to a spontaneous clearance (Farci et al., 2000; Laskus et al., 2004; Liu et al., 2012; Ray et al., 1999; Thomson et al., 2011) . The HCV quasispecies consisting of a population of divergent but closely related viruses (Martell et al., 1992) probably allows HCV to evade the immune response (Farci et al., 2000) . Longitudinally, an increase of substitutions within the HVR-1 region, which is under strong selective pressure by the immune system, are supposed to be involved in the establishment of chronic hepatitis C (Farci et al., 2000; Thomson et al., 2011) . By contrast, another study showed higher evolutionary rates in the HVR-1 over the time in patients with spontaneous clearance (Liu et al., 2012) .
The HCV NS3/4A protease is essential for HCV replication by cleaving the HCV polyprotein (Moradpour et al., 2007) , cleaves cellular Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/yviro proteins, like TC-PTP (T cell protein tyrosine phosphatase) and enhances EGF (epithelial growth factor) induced signal transduction which is essential for viral replication (Brenndorfer et al., 2009 ). Furthermore, NS3/4A blocks innate immune response signal transduction pathways by cleaving TRIF (Toll-interleukin-1 receptor domaincontaining adaptor inducing IFN) (Li et al., 2005a) and CARDIF proteins (CARD adaptor inducing IFN-ß) (also MAVS, VISA and IPS-1) (Heim, 2013; Li et al., 2005b; Meylan et al., 2005; Sklan et al., 2009) , which are important for TLR (Toll-like receptor) and RIG-I (retinoic acid inducible gene-I) mediated signalling cascades. These pathways result in the secretion of IFNs leading to the transcription of IFN-stimulated genes (ISGs) mediating cellular functions limiting HCV replication (Gale and Foy, 2005; Heim, 2013; Metz et al., 2013; Sklan et al., 2009; Thimme et al., 2012) . The inactivation of CARDIF and TRIF leads to a reduced IFN production and impaired host defences which may promote a persistent HCV infection (Bellecave et al., 2010; Sklan et al., 2009 ). The expression of ISGs is critical for the outcome of pegylated (PEG)-IFN-α/ ribavirin therapy in patients with chronic hepatitis C, as in nonresponders ISGs were already upregulated before initiation of therapy (Sarasin-Filipowicz et al., 2008) . Furthermore, CARDIF cleavage was inversely correlated with ISG expression and the cleavage extent was higher in patients with an early virological response (Bellecave et al., 2010) . However, little is known about the role of NS3 protease in patients with acute hepatitis C. In the present study, we analyzed the early NS3 protease evolution, the cleavage of CARDIF as well as viral and host factors for an elucidation of the role of the NS3 protease for the outcome of acute hepatitis C in HIV-positive patients.
Results

Baseline characteristics of the patient cohort
For analysis of evolution and function of the HCV NS3 protease, we enrolled 82 consecutive patients with acute hepatitis C and HIV coinfection into a prospective study (see the Material and methods section). The clinical characteristics of the patient cohort are shown in Table 1 . The majority of patients was infected with HCV genotype (GT) 1a (n¼ 66, 80.5%) and the median HCV viral load was 1.4 Â 10 6 IU/mL at the time of diagnosis (baseline). In our patient cohort, we observed an overall rate of spontaneous clearance of 13.4% (n¼11), and the median duration between diagnosis and spontaneous clearance was 5.5 months (range 1.1-25.1 months) (Table 1 ). In 43 patients treatment of acute hepatitis C was initiated early after a mean duration of 2.8 months (range 0.7-6.0 months) after diagnosis of acute hepatitis C and 39 of 40 patients (97.5%) who completed the follow-up visits after acute hepatitis C therapy, achieved a SVR and one subject had a relapse. The majority of treated patients (93.0%, n¼40) received a dual PEG-IFN-α/ribavirin combination therapy according to the clinical recommendations (EASL, 2014) . A PEG-IFN-α monotherapy was administered to one patient, one individual was treated with PEG-IFN-α/ribavirin/telaprevir within the context of an open label trial and another patient obtained PEG-IFN/ribavirin/bocepevir (data not shown). Due to different reasons acute HCV-infection of 29.3% (n¼24) individuals was not treated within 6 months after diagnosis leading to the development of chronic hepatitis C in those patients.
Phylogenetic analyses of NS3 proteases sequences
We constructed a neighbour-joining phylogenetic tree out of NS3 protease nucleotide sequences from all patients at baseline who enabled a PCR amplification of the NS3 protease (n ¼72). An infection of single patients with several different HCV strains was not detectable based on population based sequencing. On the basis of the phylogenetic tree ( Fig. 1) we observed highly related NS3 protease sequences. In line with definitions of a previous study (van de Laar et al., 2009) , we applied bootstrap values of 470 to identify phylogenetic groups (see the Materials and methods section). Using this approach, seven groups within the cohort of GT1a-infected patients (n ¼61) were identified who were infected with similar HCV strains as well as one group consisting of individuals infected with GT4d (n¼ 9) ( Fig. 1 ). As the cohort contains only one individual each infected with GT1b and 3a respectively, these sequences could not be assigned to a group. The low number of different circulating strains indicates that only a few evolutionary closely related HCV strains are transmitted among patients of our cohort of HIV-positive MSM.
Baseline NS3 quasispecies complexity and diversity
In order to investigate the characteristics of the NS3 quasispecies of patients with acute hepatitis C, we performed clonal sequencing analyses of patient samples collected at the time of diagnosis of acute hepatitis C. We selected patients of three groups with different outcomes: spontaneous clearance (SC) versus SVR after treatment of acute hepatitis C (SVR) and development of a chronic hepatitis C (cHCV). As a reference group, NS3 protease sequencing data obtained from a previous study of patients with a long-term chronic hepatitis C (LT cHCV) was included in our analyses (Sarrazin et al., 2007) . Based on the NS3 protease amino acid sequences, the Shannon Entropies and Hamming Distances were calculated for each sample. At baseline, the median Hamming Distance in patients with spontaneous clearance was not significantly different compared to individuals achieving an treatment-induced SVR as well as compared to patients with a development of a chronic hepatitis (median 0.0099 SC, 0.0116 SVR aHCV, 0.0087 cHCV, P¼0.4951) (Fig. 2) . Also the median Shannon Entropy was comparable for all patients with an acute hepatitis C irrespective of the outcome. C (median 0.0320 SC, 0.0341 SVR aHCV, 0.0260 cHCV, P¼0.5739). Furthermore, we observed no correlation of Hamming Distances or Shannon Entropies with the HCV viral load (data not shown). Interestingly, when we compared both parameters in patients with acute hepatitis C versus individuals with a long-term chronic hepatitis C, we detected significantly higher Hamming Distances and Shannon Entropies (both Po0.0001) across all different groups of acute hepatitis C in comparison to patients with a longterm chronic hepatitis C. And also for each single acute hepatitis C outcome group these differences were significant compared to subjects with a long-term chronic hepatitis C (Fig. 2) . These results indicate that a higher quasispecies evolution (summarizing viral diversities calculated by Hamming Distances and viral complexities calculated by Shannon Entropies) is occurring during acute hepatitis C in comparison to a long-term persisting chronic HCV infection. However, we consider that the outcome of acute hepatitis C is not predictable by the baseline NS3 quasispecies complexity or diversity.
Longitudinal NS3 quasispecies analyses
To determine whether the NS3 quasispecies changes during the course of acute hepatitis C in correlation with the clinical outcome, we conducted longitudinal clonal NS3 quasispecies investigations during the first 24 weeks after diagnosis of acute hepatitis C and calculated the Hamming Distances and Shannon Entropies for patients with spontaneous clearance, SVR after treatment und individuals with a development of a chronic hepatitis C. The values of both parameters at baseline were subtracted from respective parameters determined within the time intervals T1 (week 1 to week 4), T2 (week 5 to week 9) and T3 (week 10 to week 24) after diagnosis and the median change was calculated ( Fig. 3 ). Most patients with spontaneous clearance had an early and strong viral load decline, therefore sequencing data of several patients is available only for BL and T1. As therapy was initiated after a median duration of 2.8 months after diagnosis, sequencing data of several patients with SVR after acute hepatitis C therapy is available at BL, T1 and T2 but not at T3. For patients with progression to chronic hepatitis C sequencing data sets from all time points are available. Because of this, we only compared BL-T1 and BL-T2 for further analyses. When the longitudinal development of Hamming Distances and Shannon Entropies during the different time intervals was analyzed within each outcome group, we detected a significantly increasing NS3 quasispecies evolution in patients with a development of a chronic hepatitis C between BL-T1 (P o0.05) ( Fig. 3A and B, see asterisks). All other longitudinal quasispecies changes were not significant within the single groups. Next, we compared the median delta Hamming Distances and Shannon Entropies changes for each time interval between the different outcome groups. Early after diagnosis of acute hepatitis C (BL-T1), patients with spontaneous clearance showed a decrease in the median delta Hamming Distance and Shannon Entropy compared to individuals with SVR or development of a chronic hepatitis C, and this trend was significant ( Fig. 3A and B , P ¼0.0191 and P ¼0.0152). Within the second time interval (BL-T2) only patients with an SVR and with chronic hepatitis C could be compared (see above). The BL-T2 comparison shows that the median delta Hamming Distances and Shannon Entropies are in a similar range for both groups, confirming the results of the BL-T1 comparison ( Fig. 3A and B , P¼ 0.4033 and P ¼0.3121). These results suggest, that during the early phase of acute hepatitis C, the NS3 quasispecies diversity and complexity is decreasing in patients with spontaneous clearance in comparison to patients with a later SVR or a development of a chronic hepatitis C.
Cleavage of CARDIF by NS3 patient proteases
To investigate the hypothesis that differences in the cleavage activity of patient NS3 proteases for molecules of the innate immune system may be responsible for the different outcomes of acute hepatitis C, we transfected baseline major patient NS3/4A isolates in cells expressing CARDIF, which is an essential protein in mediating innate immune signalling pathways (Sklan et al., 2009) . For the analysis of the cleavage of CARDIF, patients were chosen for which clonal NS3 protease quasispecies analyses were already performed. We selected 5 individuals with development of chronic hepatitis C and 4 patients who achieved a spontaneous clearance. Patients with an SVR after treatment of acute hepatitis C were not considered for these analyses, as therapy was initiated early before week 24 after diagnosis (see above) and these patients may not have had the possibility of spontaneously clearing the acute hepatitis C. The extent of CARDIF cleavage by patient NS3/4A isolates was determined by a transient transfection and following Western Blot analysis (see the Materials and methods section). Interestingly, CARDIF was cleaved by all patient NS3/4A isolates, although full-length CARDIF was also detectable. The CARDIF cleavage efficiency was independent of the later clinical outcome of acute hepatitis C as well as from the corresponding HCV viral load ( Fig. 4 ). However, the expression levels of the NS3 protease were highly variable and in some patient samples no NS3 expression was detectable at all ( Fig. 4 ). When we tested the NS3 expression with a FLAG antibody in a respective expression construct, we detected a similar variable NS3 expression as with the anti NS3 antibody (data not shown). Also the transfection of increasing DNA amounts resulted not in increased CARDIF cleavage levels. The NS3 expression was increased in some, but not all patients (see Supplementary Figure) . This indicates that low NS3 amounts are sufficient for an efficient cleavage of CARDIF. We conclude that CARDIF cleavage by patient NS3 proteases at baseline differs not markedly and is furthermore not able to predict the outcome of acute hepatitis C.
Analysis of clinical and laboratory parameters in correlation with outcome of acute hepatitis C
Several baseline laboratory parameters and genetic factors have been described in association with the spontaneous clearance of acute hepatitis C (Grebely et al., 2011 (Grebely et al., , 2014 Liu et al., 2012; Thomas et al., 2009; Thomson et al., 2011) . Therefore, we investigated different baseline parameters in association with outcome of acute hepatitis in patients with spontaneous clearance versus individuals developing a chronic hepatitis C using univariate analyses ( Table 2 ). The liver enzyme levels and bilirubin were elevated in patients with spontaneous clearance compared to persons with progression to chronic hepatitis C, but these differences were not significant (ALT 584 versus 314 U/L, P¼ 0.2240; AST 278 versus 159 U/L, P ¼0.2832). The proportion of patients with favourable IL28B genotypes was higher in patients with spontaneous clearance versus chronic hepatitis C, but again the differences were not significant (rs12979860 63.6% versus 50.0%, P ¼0.1493 and rs8099917, 90.9% versus 70.8%, P ¼0.3875). The IP10 levels were nearly equal in both groups and were also not able to predict the outcome of acute hepatitis C (424 pg/mL SC versus 439 pg/mL cHCV, P ¼0.8474). The baseline HCV viral load was lower in patients with spontaneous clearance, but this was not significantly different in comparison to individuals with chronic hepatitis C (1.5 Â 10 6 versus 2.3 Â 10 6 IU/mL, P ¼0.9303). Interestingly, when we calculated the median spontaneous maximal HCV viral load drop within the first 12 weeks after diagnosis of acute hepatitis C, we observed a significantly higher HCV viral load decline in individuals with spontaneous clearance compared to chronic hepatitis C (median log 10 3.5 versus 1.7 IU/mL, P¼ 0.0135), which might serve as helpful additional parameter in predicting spontaneous clearance.
Discussion
Besides strong immunological T-cell and neutralizing antibody responses, also several other host and viral factors have been shown to be associated with spontaneous clearance (Aka et al., 2014; Beinhardt et al., 2012; Bowen and Walker, 2005 Neighbour-joining phylogenetic tree based on HCV NS3 protease sequences of HIV coinfected MSM. A bootstrap analysis with 1000 replicates was performed to identify phylogenetic groups of HCV strains. One group consists of phylogenetically similar sequences with a bootstrap value 470 and bootstrap values 470 are indicated at the branch nodes. As only single individuals were infected with GT1b and 3a respectively, an assignment of these sequences to phylogenetic groups was not possible. Terczyńska-Dyla et al., 2014; Thomas et al., 2009; Thomson et al., 2011; van den Berg et al., 2011) . Regarding the evolution of the HCV quasispecies during acute hepatitis C, studies mainly concentrated on the investigation of the E2 HVR1 region (Farci et al., 2000; Laskus et al., 2004; Liu et al., 2012; Ray et al., 1999) or on the HVR1 region in combination with NS5B ( Thomson et al., 2011) . One single report is based on the analysis of the NS3 protease evolution at the time of diagnosis of acute hepatitis C, but without including patients with spontaneous clearance or longitudinal samples (Nevot et al., 2014) . Here, we performed longitudinal clonal NS3 protease quasispecies analyses and investigated the cleavage of CARDIF in correlation with the outcome of acute hepatitis C in a HIV-coinfected cohort in order to investigate the role of the NS3 protease during acute hepatitis C.
First, we examined several clinical parameters in association with outcome in our cohort of 82 MSM with acute hepatitis C and HIV coinfection. The rate of spontaneous clearance was relatively low (13.4%) compared to other studies which investigated HCV monoinfected patients with spontaneous clearance rates of approximately 25% (Grebely et al., 2011; Sklan et al., 2009 ). Spontaneous clearance rates in a similar range have been reported by other studies investigating HIV-coinfected cohorts (Thomson et al., 2011) . As multispecific CD4 and CD8 T-cell responses are associated with HCV recovery, lower spontaneous clearance rates in HIV-coinfected patients are expectable due to long-term HIV-coinfection (Low et al., 2008) . Furthermore, treatment was initiated early (median 2.8 months after diagnosis), possibly not enabling a spontaneous clearance in some cases, as in our cohort spontaneous clearance occurred at a median time of 5.5 months after diagnosis.
Interestingly, based on NS3 protease nucleotide sequence analyses at the time of diagnosis we observed a close evolutionary relationship of NS3 sequences, indicating that acute hepatitis C is caused by a relatively small number of closely related HCV strains. Similar observations with evidence of a large international network of HCV transmission in HIV-positive MSM were obtained in previous studies showing low evolutionary distances among HCV isolates within a region of the NS5B gene and a clustering of these sequences (Nevot et al., 2014; van de Laar et al., 2009) . Therefore, we assume that our patients are part of this international network. When we clonally analyzed the NS3 proteasse quasispecies evolution at the time of diagnosis of acute hepatitis C, we detected that the quasispecies diversities (Hamming Distances) and complexities (Shannon Entropies) were in a similar range for all patients, irrespective of the later outcome (spontaneous clearance versus SVR after treatment versus chronic hepatitis C). Interestingly, we observed a significantly higher NS3 quasispecies diversity and complexity in all patients with acute hepatitis C compared to individuals with a long-term chronic HCV infection. This is in contrast with the results of Nevot et al. (2014) who found at baseline significantly lower NS3 quasispecies heterogeneities as well as complexities in acutely HCV infected MSM compared to patients with a long-term chronic hepatitis C. But this study did not analyze consecutive samples and also the investigation of patients with spontaneous clearance was lacking, allowing no conclusion of the influence of the quasispecies evolution on outcome. Also other studies (Farci et al., 2000; Thomson et al., 2011) showed a diversification in HVR-1 in patients progressing to chronic hepatitis C. Our conflicting result of a reduced HCV quasispecies in long-term chronic hepatitis C could in principle also be attributed to the fact that these patients were not HIVcoinfected. Unfortunately, as an acute hepatitis C is mostly asymptomatic and therefore not diagnosed, the establishment of a large acute HCV-monoinfected cohort with frequent sampling during the acute phase of infection is difficult. However, several studies investigated the HCV quasispecies evolution in patients with chronic hepatitis C monoinfection versus HCV/HIV coinfection. A decreased NS3 and HVR quasispecies variability was found in patients with HIV coinfection compared to HCV monoinfection (Jabara et al., 2014; Shuhart et al., 2006) . This effect appeared to be reversed by effective ART (Shuhart et al., 2006) . But other researchers could not detect any difference in HCV quasispecies diversity between HCV-moninfected versus HIV-coinfected individuals (Netski et al., 2008) or between HIV-coinfected patients receiving ART or not (Winters et al., 2010) . In acute hepatitis C, comparisons between HCV monoinfected and HIV-coinfected patients were performed only by the above mentioned study (Nevot et al., 2014) which showed no differences in the NS3 quasispecies heterogeneity and complexity between both groups. Although, we cannot completely rule out that the observed differences between acute and long-term hepatitis C are 1.4 (0.5-3.6) 0.7 (0.3-10.9) ¼ 0.1439 1 HCV GT (1a/non1a) [n ] 9/2 22/2 ¼ 0.5748 2 HCV viral load (IU/mL) [median (range)] 1.5 Â 10 6 (127-6.9 Â 10 7 ) 2.3 Â 10 6 (119-8.7 Â 10 7 ) ¼ 0.9303 1 Max. HCV-VL log 10 decline (IU/mL) [median (range)] within 12 weeks 3.5 (0.7-6.4) 1.7 (0.2-5. influenced by HIV coinfection of different ART regimens in the acute cohort, we assume that this a rather weak effect. In our opinion the unexpected result of a decreased quasispecies variability during chronic hepatitis C is attributable to the ability of HCV to evade cellular immunity. Cellular immune responses during chronic hepatitis C have an isolate-specific activity and may be ineffective against divergent strains in the quasispecies. This could lead to the emergence of cytotoxic T lymphocyte (CTL) epitope variants resulting in a loss of CTL recognition which are then selected during long-term chronic hepatitis C leading to a homogenization of the quasispecies (Freeman et al., 2001) . Our results show that the NS3 protease is a target of the immune system during acute hepatitis C. Of note, we detected no selection of specific mutations within the NS3 protease neither at baseline nor longitudinally in association with outcome (data not shown). As we were not able to detect significant differences in the NS3 quasispecies diversity and complexity at the time of diagnosis of acute hepatitis C in correlation with outcome, longitudinal samples were investigated. When T1 samples (collected within week 1 and 4 after diagnosis) were compared with baseline samples, patients with spontaneous clearance showed a significant trend to decreasing Delta Hamming Distances and Shannon Entropies compared to individuals who achieved a SVR after treatment or developed a chronic hepatitis C. These observations are consistent with other studies which investigated the evolution of the HVR-1 region within the E2 gene during acute hepatitis C. These studies revealed in longitudinal samples of patients with spontaneous clearance a decreased quasispecies evolution compared to individuals with development of a chronic hepatitis C (Farci et al., 2000; Laskus et al., 2004; Thomson et al., 2011) . Interestingly, in two of these studies (Farci et al., 2000; Thomson et al., 2011) the baseline Hamming Distances were also not significantly different between patients with spontaneous clearance compared to chronic hepatitis C, as shown in our study. Therefore, we assume, that a prediction of the outcome of acute hepatitis C is probably not possible based on the baseline NS3 quasispecies diversity and complexity but the early evolution within week 1 and 4 after diagnosis may be supportive to identify patients which are able to spontaneously clear the acute hepatitis C infection. When instead of amino acids, nucleotide sequences were used for the calculation of Hamming Distances and Shannon Entropies, the absolute values were slightly lower. This indicates that most nucleotide changes result in amino acid changes, possibly reflecting the evolutionary pressure on NS3 during acute hepatitis C. However, nucleotide Shannon Entropies and Hamming Distances were also significantly decreasing in patients with spontaneous clearance compared to individuals with a progression to chronic hepatitis C within the first 4 weeks after diagnosis (data not shown).
To investigate the function of patient NS3 proteases with respect to the cleavage of molecules of the innate immune system, we examined the cleavage of the CARDIF protein in cell culture. Here, we observed that CARDIF cleavage was comparable at baseline, irrespective of the later outcome of acute hepatitis C. Previous studies of patients with chronic hepatitis C based on an bacteriophage in vitro assay or liver biopsies showed individual differences in the cleavage of CARDIF with some individuals exerting no CARDIF cleavage activity at all (Aparicio et al., 2011; Bellecave et al., 2010) . The investigations of the CARDIF cleavage performed by Nevot et al. (2014) were based on a bacteriophage screen also applied by Aparicio et al. (2011) and showed that NS3 proteases from patients with acute hepatitis C exhibited a greater efficiency for CARDIF cleavage in comparison to individuals with chronic hepatitis C but the cohort contained no patients with spontaneous clearance. Interestingly, we observed highly variable NS3 expression profiles in our patients which did not correlate with the HCV viral load. The transfection of increasing DNA amounts did not lead to an increased CARDIF cleavage and as CARDIF is efficiently cleaved also in patients with no detectable NS3 expression, we think that already small NS3 amounts are sufficient for the cleavage.
Investigations of liver biopsies of patients with chronic hepatitis C revealed that cleavage of CARDIF negatively correlated with the activation of the endogenous IFN system (Bellecave et al., 2010) . However, in liver biopsies of patients with acute hepatitis C no CARDIF cleavage was detectable at all. As these biopsies were obtained 2-5 months after HCV transmission, the authors state that they were taken during a relatively late phase of acute hepatitis C. The same study showed enhanced induction of IFN-γ specific ISGs during acute hepatitis C compared to IFN-α ISGs which were expressed in patients with chronic hepatitis C (Dill et al., 2012) . Altogether, a different pattern of ISGs is expressed during acute hepatitis C and furthermore the linkage of CARDIF cleavage with ISG-/NS3-expression and outcome of acute hepatitis C remains to be further investigated. We can conclude that the patient NS3 isolates of our cohort in principle are all able to cleave CARDIF in cell culture. However, whether the signalling of the innate immune system during the early phase of acute hepatitis C may be impaired and whether the ability of the NS3 protease to cleave CARDIF at all is of importance for the outcome of acute hepatitis C remains unclear.
We also examined the influence of other clinical and laboratory parameters in correlation with the outcome of acute hepatitis C. Known factors in association with spontaneous clearance are favourable IL28B genotype, female sex and HCV genotype 1 (Grebely et al., 2014; Thomas et al., 2009; van den Berg et al., 2011) , higher initial HCV viremia (Liu et al., 2012) and lower IP10 levels (Beinhardt et al., 2012; Grebely et al., 2013) . Furthermore, spontaneous clearance has been shown to be predictable by a rapid decline in HCV RNA levels, elevated bilirubin and ALT levels as well as high CD4 counts (Thomson et al., 2011) . We also observed in our patient cohort a tendency to correlation of favourable IL28B genotypes and higher ALT and bilirubin levels with spontaneous clearance, although these differences were not significant, which is presumably due to the relatively small patient numbers. IP10 levels as well as the initial viral load were not able to predict spontaneous clearance in our cohort. However, we detected a significantly higher maximal HCV viral load decline in patients with spontaneous clearance in comparison to patients with development of chronic hepatitis C within the first 12 weeks after diagnosis. Other researchers also found that a more than 2 log 10 drop of the HCV viral load within the early phase of acute infection is associated with spontaneous clearance (Kamal et al., 2014; Thomson et al., 2011) . Nevertheless our study is limited to identify baseline factors in association with outcome of acute hepatitis C, as treatment was initiated early, limiting the numbers of untreated patients necessary for these comparisons. However, an early onset of acute hepatitis C therapy is recommended in HIVcoinfected patients 3 months after diagnosis at latest by the guidelines from the European AIDS clinical society (EACS, 2014 ). An additional limitation may be a clonal instead of deep sequence analysis although the importance of minor quasispecies for the outcome of acute hepatitis C is questionable.
In conclusion, although our study has a relative small overall cohort size, our findings suggest a role of the early HCV quasispecies evolution in determining the outcome of acute hepatitis C. In contrast to a long-term persisting chronic hepatitis C, an acute hepatitis C is characterized by a highly diverse and complex NS3 protease quasispecies, which is not able to predict outcome at baseline. Functional analyses of CARDIF cleavage by patient NS3 proteases showed also no marked differences. Therefore, pathways of the innate immune system including CARDIF may not have an essential role in determining the outcome of acute hepatitis C. In summary an early and decreasing NS3 protease evolution together with a high HCV viral load decline, as a result of an effective immune response against HCV, are able to predict spontaneous clearance of acute hepatitis C.
Materials and methods
Patients
In a prospective study, blood was collected from 82 consecutive patients with an acute HCV infection and a HIV coinfection (confirmed by a positive HIV antibody test) at the University Hospital and the Infectious-Disease Medical Center (Infektiologikum) in Frankfurt am Main, Germany between 2009 and 2013. Acute hepatitis C was diagnosed within the routine laboratory examination of HIV-infected patients. Definition of acute hepatitis C was based on previous studies (European A.T.N.A.H.C.I.C.P., 2011; Ingiliz et al., 2014) : (1) HCV antibody positivity plus HCV RNA positivity and a negative HCV antibody test within the last 12 months, (2) HCV RNA detectability and a documented negative HCV-RNA and HCV antibody test within the last 12 months (3) HCV-RNA positivity and ALT elevation of more than 5 times of the upper limit of the normal range and normal ALT within the last 12 months. We collected serum and EDTA blood at the time of diagnosis of acute hepatitis C infection (baseline) and during the following routine medical visits, serum samples were taken longitudinally (approximately every 4 weeks over a 6 month period). Collection of samples was stopped after HCV RNA negativity after starting of HCV treatment or after confirmed spontaneous clearance. Viral and biochemical laboratory parameters were documented for each time point when serum was collected. Spontaneous clearance was defined as negative HCV RNA detected twice within an interval of at least 12 weeks without receiving therapy and confirmation 6 months after diagnosis of acute hepatitis C. Sustained virologic response (SVR) was determined by HCV RNA negativity 12 weeks after the end-of-treatment. Chronic hepatitis C was defined as the presence of HCV RNA 24 weeks after diagnosis without treatment. The NS3 protease was population-based sequenced in all patient samples at baseline which yielded in a PCR product (n¼ 72/82) after performing at least 3 independent experiments. The viral load of 9 patients whose samples yielded in no PCR product was low (o8000 IU/mL), however one patient displayed a very high viral load and the sample was not amplifiable at all (median¼166 IU/mL, range o15-3.5 Â 10 7 ). For clonal NS3 quasispecies (baseline and longitudinally before initiation of therapy/spontaneous clearance) and CARDIF cleavage investigations (baseline), patients with sufficient longitudinal sampling and a high enough viral load (41000 IU/mL) were selected out of different groups (spontaneous clearance versus SVR after acute hepatitis C therapy versus progression to chronic hepatitis C) (see the Results section). Altogether, we performed longitudinal clonal NS3 analyses of 6 patients with spontaneous clearance, 5 individuals with treatment-induced clearance of acute hepatitis C and 9 patients with chronic hepatitis C. For the investigation of the CARDIF cleavage at baseline, out of these patients, 5 individuals with progression to chronic hepatitis C and 4 individuals with spontaneous clearance were selected. Approval of the enrollment in the observational study as well as the usage of patient blood samples for research purpose was obtained from the local ethics committee, and written informed consent was obtained from all patients.
HCV RNA extraction, reverse transcription and PCR
For the extraction of HCV RNA, 140 mL of serum was used (QIAamp Viral RNA Mini-Kit, Qiagen, Hilden, Germany) and complementary DNA (cDNA) was synthesized using SuperScript III Reverse Transcriptase (Invitrogen) as mentioned before (Dietz et al., 2013) . Nested PCRs of NS3 protease and NS3/4A were carried out using 1/20 of cDNA or outer PCR product respectively by applying the Expand High Fidelity PLUS PCR System (Roche Applied Science). Amplification of the HCV GT1 NS3 protease domain for clonal quasispecies analyses was performed with primers described previously (Lim et al., 2012) . NS3 protease amplifications of all genotypes started with an initial denaturation at 94 1C for 2 min, followed by 35 cycles at 94 1C for 30 s, 30 s at the respective annealing temperature and 72 1C for one minute and a final elongation step at 72 1C for 7 min. GT3a was amplified using NS3-3a-sense, CGGCTTGCGGAGATATTC and NS3-3a-outer-as, CCGTAGGTGGAATAGGT-CAG in the outer PCR and NS3-3a-sense and NS3-3a-inner-as, AGACAT-GAAGGAGCCGAAG in the inner PCR. The annealing temperature was 54 1C in the outer PCR and 52 1C in the inner PCR. For the amplification of GT4d, the outer PCR was conducted with NS3_4d_out_F, CCGC-TGCATGCGGTGACATTC and NS3_4d_out_R, TTCCCGTTGGCGCGTGCAAG and in the inner PCR NS3_4d_inn_F, CTTGCTCGGCCCGGCCGAC and NS3_4d_inn_rev, GGGCACGGCAGGAGGAGTGG were applied and the annealing temperature was 54 1C in both PCRs. For the utilization in the CARDIF cleavage assay, GT1a NS3/4A was amplified using NS3/ 4A_1a_out_F, ATGGAGACCAAGCTCATCACGTGGG and NS3/4A_1a_ out_R, AGGGCCTTCTGCTTGAACTGCTC in the outer PCR and NS3/ 4A_1a_NheI_inn_F, ATGATGGCTAGCGCCACCATGGCGCCCATCACRGCG-TACGCC and NS3/4A_1a_EcoRI_inn_R, ATGATGGAATTCTCACTAGCACTCTT CCATCTCATCGAACTC in the inner PCR. The initial denaturation as well as the final elongation step were performed as described above. Both PCRs were conducted with 40 cycles at 94 1C for 30 s, an annealing step for 30 s at 40 1C in the outer PCR and at 60 1C respectively in the inner PCR, followed by 72 1C for 2.5 min. The resulting PCR products were analyzed for correct size on 1% agarose gels stained with ethidium bromide.
Cloning of NS3 protease domain and NS3/4A
The PCR products of the NS3 protease domain and NS3/4A were gel-purified using the QIAquick Gel Extraction Kit (Qiagen). The NS3 protease PCR products were then cloned into the pSC-A-amp/ kan vector and transformed into Escherichia coli competent cells (StrataClone PCR Cloning Kit, Agilent Technologies). The NS3/4A PCR products were digested with NheI and EcoRI, cloned into pcDNA3.1 (þ ) vector (Invitrogen) and transformed into E. coli competent cells. The purification of plasmid DNA occurred by using the GenElute HP 96-Well Plasmid Miniprep Kit (Sigma-Aldrich) according to the manufacturer's protocol.
NS3 protease domain and NS3/4A sequencing and phylogenetic analysis
Population-based sequencing of the NS3 protease from patients at baseline was performed by using the purified PCR-product and the inner forward PCR primer. For clonal NS3 protease quasispecies analysis an average of 32 clones were sequenced for each patient using M13 reverse primer, CAGGAAACAGCTATGAC. The number of analyzed clones was in accordance with other studies which investigated the HCV quasispecies evolution during acute hepatitis C (Farci et al., 2000; Liu et al., 2012; Nevot et al., 2014; Ray et al., 1999; Thomson et al., 2011) . For usage in the CARDIF cleavage assay, at least 16 clones per patient containing NS3/4A were sequenced with the pCMV forward primer, CGCAAATGGGCGGTAGGCGTG and the BGH reverse primer, TAGAAGGCACAGTCGAGG to determine the major (most frequent) clone within the NS3 protease as well as to verify the functionality of the clones. Sanger sequencing was performed according to the manufacturer's protocol (Big Dye Terminator v1.1 Cycle Sequencing Kit, Applied Biosystems) on an ABI Prism 3130xl Genetic Analyzer (Applied Biosystems). For the generation of a phylogenetic tree, NS3 protease nucleotide sequences were aligned and a Neighbour-joining tree was computed using the MEGA 6 software (Tamura et al., 2013) . In accordance with other studies Nevot et al., 2014) a Tamura three-parameter model with a gamma distribution and a bootstrap analysis (1000 replicates) was applied and bootstrap values 470 were defined to represent robust clusters as proposed previously (van de Laar et al., 2009) . To investigate NS3 mutations, the 543 nucleotides of the NS3 protease gene (corresponding to 181 amino acids) were aligned using the software Mutational Surveyor (SoftGenetics, State College, PA). Aligned amino acid sequences of each patient and time point were analyzed for mutations in comparison to the baseline consensus sequence. Furthermore, mean Shannon Entropies and Hamming Distances were calculated for each patient and time point using an in-house software computed by Eva Herrmann based on (Sarrazin et al., 2001) . Thereby, the Shannon Entropy is a measure for the number of viral variants within the quasispecies (genetic complexity). The Hamming Distance accounts for the frequency of mutations within single isolates of the HCV quasispecies (genetic diversity). NS3 sequence data of a control group of patients (n¼34) with longterm chronic hepatitis C were obtained from a previous study (Sarrazin et al., 2007) . For longitudinal analysis of Shannon Entropies and Hamming Distances, we calculated delta values for each patient by subtracting the baseline values from the respective time point. Serum samples corresponding to time point (T) 1 were collected within weeks 1 and 4, samples corresponding to T2 were taken within weeks 5 and 9 and samples corresponding to T3 were collected within weeks 10 and 24 after diagnosis of acute hepatitis C.
Genotyping of IL28B single nucleotide polymorphisms
Genomic DNA of patient samples was extracted from EDTA blood using QIAamp DNA Blood Kit (Qiagen). For SNP genotyping of IL28B SNPs rs12979860 and rs8099917 a real-time polymerase chain reaction was performed using a StepOnePlus instrument (Applied Biosystems) as previously described (Susser et al., 2014) .
Quantification of IP-10 levels IP-10 levels were measured by using 75 mL of 1:4 diluted patient serum samples and commercially available CXCL10/IP-10 Quantikine ELISA Kit according to the manufacturer's protocol (R&D Systems).
CARDIF cleavage assay
U2OS cells expressing endogenous CARDIF protein were seeded at a density of 900,000 cells per 5 cm diameter dish in DMEM complete containing 10% FCS and 1% Pen/Strep. The following day, the medium was changed and cells were transfected with 1.7 mg of NS3/4A-pcDNA3.1 (þ) representing the major clone of the respective quasispecies using X-tremeGENE HP DNA Transfection Reagent (Roche Applied Science). 36 h after transfection, cells were harvested and proteins were extracted with RIPA lysis buffer according to Bellecave et al. (2010) containing 50 mM TrisCl pH 8.0, 150 mM NaCl, 1% NP40, 0.5% deoxcholate, 0.1% sodium dodecyl sulphate, 1 mM sodium orthovanadate, 10 mM NaF and a cocktail of protease and phosphatase inhibitors (Complete Protease Inhibitor and Phosphostop, Roche Applied Science). The protein content of samples was measured and per sample 50 micrograms protein was separated on 10% denaturating sodium dodecyl sulphate polyacryl amide gelelectrophoresis. Western Blot analysis occurred as described previously with murine anti-CARDIF antibody 1:1000 in 5%milkpowder/PBS, anti-NS3 1:500 in 3%BSA/milk/PBS and anti-actin 1:6000 5%/PBS and horseradish peroxidase-coupled secondary antibodies and Luminata Forte Western HRP Substrate (Milipore) (Bellecave et al., 2010; Wolk et al., 2000) . Transfections and Western Blot analyses were performed in three independent experiments.
Statistical analyses
We carried out statistical analyses of the data using the BIAS software (BIAS for Windows, Version 10, © Epsilon 2013). Statistical analyses of associations of continuous variables (for instance Shannon Entropies, Hamming Distances, ALT, AST, HCV viral load, IP10) with the outcome of acute hepatitis C were performed using the Wilcoxon-Mann-Whitney-U-test (comparison of 2 groups) or the Kruskall-Wallis test (comparison of 3 or more groups). To analyze for a trend between different groups, we applied the Jonckheere-Terpstra-Test. When time courses of Shannon Entropies and Hamming Distances were compared within each patient group, the Wilcoxon-Matched-Pairs test was applied. For the analysis of dichotomic variables (single-nucleotide-polymorphism (SNPs), HCV genotype) we used fourfold tables (Chi-square test, Fisher's exact test if more than 20% of expected frequencies were less than 5). P-values of less than 0.05 were considered significant.
